Company
Headquarters: Toronto, ON, Canada
Employees: 1
CEO: Mr. Douglas K. Gordon
No stock data available
Company | Market Cap (USD) |
---|---|
Lilly | $689.42 B |
Novo Nordisk | $622.07 B |
UnitedHealth Group | $487.54 B |
Johnson & Johnson | $353.05 B |
AbbVie | $301.60 B |
Silo Wellness Inc., a psychedelics company, develops psychedelic medicine to reduce trauma. It focuses on developing psilocybin-free functional mushroom tinctures; and the formulation of a psilocybin nasal spray in Jamaica. The company also offers Jamaican and Oregon psychedelic wellness retreats, as well as cultivates psychedelic mushrooms in Jamaica. Silo Wellness Inc. is headquartered in Toronto, Canada.
Silo Wellness, Inc. has the following listings and related stock indices.
Stock: CSE: SILO wb_incandescent